Video

Nanoform Capacity Update October 2025: Large Molecule

Source: Nanoform

Sergie Letser, Deputy CCO, presents an overview of Nanoform’s novel large molecule nanoforming technology capabilities and current capacity. Nanoform's approach allows for the development of alternative delivery routes that otherwise wouldn’t be possible with traditional formulation approaches, including development of high concentration (>400mg/ml dose in a single 2mL syringe) formulations for subcutaneous injection as well as novel formulations for pulmonary delivery.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Nanoform